Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

PanOptix and AT LISA tri in presbyopic surgery

Search Title by author or title

Session Details

Session Title: Presbyopia Management

Session Date/Time: Sunday 08/10/2017 | 16:30-18:00

Paper Time: 17:09

Venue: Room 2.1

First Author: : M.Kacerovsky CZECH REPUBLIC

Co Author(s): :    J. Kacerovska                    

Abstract Details


Comparison between PanOptix and AT LISA trifocal IOLs.We compared the six-month visual acuity, photic outcomes and posterior capsule opacification ( PCO) rates in patients who received bilateral Panoptic implants and AT LISA tri implants.


Eye Clinic Horni Pocernice, Prague, Czech republic


Bilateral implantation of PanOptix implants (n=100, 200 eyes) and AT LISA tri implants (n=100, 200 eyes). All patients underwent femtosecond laser-assisted surgery with an Alcon LenSx system- and baseline demographic and refractive error was similar in both groups. Uncorrected visual acuity at distance, near (40 cm) and at two intermediate distances ( 60 and 80 cm) were assessed. Halo and glare rates were observed. Numbers of eyes which required Nd:YAG capsulotomies for PCO after six months were compared in both groups.


Uncorrected visual acuity was similar for both trifocal IOLs at distance, near and 80 cm, but PanOptix was significantly better (p=0.039) than AT LISA tri at 60 cm distance. Halo and glare rates were similar for both trifocal IOLs. 70% of patients who received either lens experienced these phenomenas rarely or never. After six months, only one eye (0,5%) that received a PanOptix IOL required Nd: YAG capsulotomy for PCO, whereas statistically significantly more eyes ( n=12, 6%, p= 0,021) that received AT LISA tri required this procedure.


Both IOLs performed in a similar way (visual acuity, halos, glare and patient satisfaction), but patients receiving PanOptix showed superior visual acuity at 60 cm and required fewer Nd: YAG procedures than those who received AT LISA tri.

Financial Disclosure:


Back to previous